VACCENTIS
Vaccentis AG develops and produces patient-specific medicines. On the basis of complementary and natural medicine and the achievements of evidence-based medicine, they ensure that the proven medicines for autologous patient treatment are consistently perfected.
VACCENTIS
Industry:
Health Care
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.vaccentis.com
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Mobile Non Scaleable Content Apache DigiCert SSL Encryption Everywhere Maxi Menu CK
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Lanier Biotherapeutics
Lanier Biotherapeutics develops antibody treatments for specialty diseases.
Lutris Pharma
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
Siduma Therapeutics
Siduma Therapeutics builds a disruptive new class of medicines for better healthcare.
Current Employees Featured
Key Employee Changes
Official Site Inspections
http://www.vaccentis.com Semrush global rank: 13.75 M Semrush visits lastest month: 74
- Host name: 217-160-0-8.elastic-ssl.ui-r.com
- IP address: 217.160.0.8
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Vaccentis"
Home – Vaccentis
On 24 June, Vaccentis held a cross-functional Advisory Board under the leadership of our Head… The Annual General Meeting of Vaccentis AG took place on 20 June 2024 at the offices of… Take a look at a scientific report on …See details»
COMPANY – Vaccentis
Vaccentis AG is a Zurich-based company focused on the biotech and pharmaceutical sector. All research, production and sales activities of the are carried out by two highly specialised …See details»
Vaccentis AG - Swiss Biotech
VACCENTIS AG is a Zurich-based investment company focused on the biotech and pharmaceutical sector. The entire research, production and sales …See details»
Vaccentis - Crunchbase Company Profile & Funding
Vaccentis AG develops and produces patient-specific medicines. On the basis of complementary and natural medicine and the achievements of evidence-based medicine, they ensure that the …See details»
01/2024 - Vaccentis
Starting 2024 with an outlook on our goals ? ???? Further build R&D organization hiring additional internal HR resources ? Further build preclinical models and extend research activities …See details»
Vaccentis - LinkedIn
? Today is my second anniversary as CEO of #Vaccentis. ? What have we achieved in the last 2 years? ? We have built a great team with Ingrid Rauter at the head of our R&D organisation. ? We...See details»
Vaccentis AG Company Profile | Zürich, ZÜRICH, Switzerland ...
Find company research, competitor information, contact details & financial data for Vaccentis AG of Zürich, ZÜRICH. Get the latest business insights from Dun & Bradstreet.See details»
Vaccentis at the Swiss Biotech Day
Vaccentis is a Zurich-based company focused on the biotech and pharmaceutical sector. All research, production and sales activities are carried out by two highly specialised subsidiaries, …See details»
Vaccentis AG - Life-Sciences-Europe.com
Jul 12, 2022 · Vaccentis AG is a clinical-stage Swiss biopharmaceutical company developing patient-specific medicines to improve patients’ chances of recovery from chronic and …See details»
Schweizer Biotech- und Pharma-Unternehmen ist führend in …
Jan 25, 2024 · Nebst Big Playern aus den USA ist auch das Schweizer Biotech- und Pharma-Unternehmen Vaccentis aus Zürich auf bestem Weg, eine individuell abgestimmte …See details»
06/2024 - Vaccentis
The Annual General Meeting of Vaccentis AG took place on 20 June 2024 at the offices of Lenz & Staehelin in Zurich. In an informative programme, we were able to highlight the key status of …See details»
Vaccentis - Contacts, Employees, Board Members, Advisors
Vaccentis has 3 current employee profiles, including Chief Medical Officer and Head of Research and Development Ingrid Rauter. Vaccentis AG develops and produces patient-specific medicines.See details»
Vaccentis appoints Martin Munte as CEO and strengthens Board
Vaccentis AG is a clinical-stage Swiss biopharmaceutical company developing patient-specific medicines to improve patients’ chances of recovery from chronic and malignant diseases. …See details»
Vaccentis appoints Martin Munte as CEO and strengthens Board
Jul 12, 2022 · Vaccentis AG, a clinical-stage Swiss biopharmaceutical company developing patient-specific medicines, today announced the appointment of Martin Munte, a veteran …See details»
Vaccentis appoints Martin Munte as CEO and strengthens
Jul 12, 2022 · Vaccentis AG is a clinical-stage Swiss biopharmaceutical company developing patient-specific medicines to improve patients’ chances of recovery from chronic and …See details»
NEWS - Vaccentis
On 24 June, Vaccentis held a cross-functional Advisory Board under the leadership of our Head… The Annual General Meeting of Vaccentis AG took place on 20 June 2024 at the offices of…See details»
Immunization - Bill & Melinda Gates Foundation
As part of Gavi, the Vaccine Alliance, we work with country governments, nongovernmental organizations, the World Health Organization (WHO), UNICEF, and a wide range of other …See details»
CONTACT - Vaccentis
Thank you for contacting us using the form below. We will get back to you as soon as possible.See details»
Gates Offers Grim Global Health Report, and Some Optimism
Sep 14, 2020 · Bill Gates, co-founder of Microsoft and the Bill and Melinda Gates Foundation, wants to add $4 billion to the fiscal stimulus package under debate in Congress so that poor …See details»
PIPELINE - Vaccentis
Only One In 10,000 Substances Tested In Research Laboratories Will Eventually Become A Drug After About 12 Years. The Cost Is 1–1.5 Billion Us Dollars.See details»